Subscribe to RSS
DOI: 10.1055/s-2002-20059
© Georg Thieme Verlag Stuttgart · New York
Mechanisms of Relaxant Action of 3-O-Methylquercetin in Isolated Guinea Pig Trachea
Publication History
January 26, 2001
August 4, 2001
Publication Date:
31 January 2002 (online)
![](https://www.thieme-connect.de/media/plantamedica/200201/lookinside/thumbnails/10.1055-s-2002-20059-1.jpg)
Abstract
We investigated the mechanisms of action of 3-O-methylquercetin (3-MQ), isolated from Rhamnus nakaharai (Hayata) Hayata (Rhamnaceae) which is used as a folk medicine for treating constipation, inflammation, tumors and asthma in Taiwan. The tension changes of tracheal segments were isometrically recorded on a polygraph. 3-MQ concentration-dependently relaxed histamine (30 μM)-, carbachol (0.2 μM)- and KCl (30 mM)-induced precontractions, and inhibited cumulative histamine-, and carbachol-induced contractions in a non-competitive manner. 3-MQ also concentration-dependently and non-competitively inhibited cumulative Ca2+-induced contractions in depolarized (K+, 60 mM) guinea-pig trachealis. The nifedipine (10 μM)-remaining tension of histamine (30 μM)-induced precontraction was further relaxed by 3-MQ, suggesting that no matter whether VDCCs were blocked or not, 3-MQ may have other mechanisms of relaxant action. The relaxant effect of 3-MQ was unaffected by the removal of epithelium or by the presence of propranolol (1 μM), 2′,5′-dideoxyadenosine (10 μM), methylene blue (25 μM), glibenclamide (10 μM), N ω-nitro-L-arginine (20 μM), or α-chymotrypsin (1 U/ml). However, 3-MQ (7.5 - 15 μM) and IBMX (3 - 6 μM), a positive control, produced parallel and leftward shifts of the concentration-response curve of forskoline (0.01 - 3 μM) or nitroprusside (0.01 - 30 μM). 3-MQ or IBMX at various concentrations (10 - 300 μM) concentration-dependently and significantly inhibited cAMP- and cGMP-PDE activities of the trachealis. The IC50 values of 3-MQ were estimated to be 13.8 and 14.3 μM, respectively. The inhibitory effects of 3-MQ on both enzyme activities were not significantly different from those of IBMX, a non-selective PDE inhibitor. The above results reveal that the mechanisms of relaxant action of 3-MQ may be due to its inhibitory effects on both PDE activities and its subsequent reducing effect on [Ca2+]i of the trachealis.
Abbreviations
3-MQ:3-O-methylquercetin
IBMX:3-isobutyl-1-methylxanthine
VDCCs:voltage dependent calcium channels
cAMP:adenosine 3′,5′-cyclic monophosphate
cGMP:guanosine 3′,5′-cyclic monophosphate
PDE:phosphodiesterase
Abstract
We investigated the mechanisms of action of 3-O-methylquercetin (3-MQ), isolated from Rhamnus nakaharai (Hayata) Hayata (Rhamnaceae) which is used as a folk medicine for treating constipation, inflammation, tumors and asthma in Taiwan. The tension changes of tracheal segments were isometrically recorded on a polygraph. 3-MQ concentration-dependently relaxed histamine (30 μM)-, carbachol (0.2 μM)- and KCl (30 mM)-induced precontractions, and inhibited cumulative histamine-, and carbachol-induced contractions in a non-competitive manner. 3-MQ also concentration-dependently and non-competitively inhibited cumulative Ca2+-induced contractions in depolarized (K+, 60 mM) guinea-pig trachealis. The nifedipine (10 μM)-remaining tension of histamine (30 μM)-induced precontraction was further relaxed by 3-MQ, suggesting that no matter whether VDCCs were blocked or not, 3-MQ may have other mechanisms of relaxant action. The relaxant effect of 3-MQ was unaffected by the removal of epithelium or by the presence of propranolol (1 μM), 2′,5′-dideoxyadenosine (10 μM), methylene blue (25 μM), glibenclamide (10 μM), N ω-nitro-L-arginine (20 μM), or α-chymotrypsin (1 U/ml). However, 3-MQ (7.5 - 15 μM) and IBMX (3 - 6 μM), a positive control, produced parallel and leftward shifts of the concentration-response curve of forskoline (0.01 - 3 μM) or nitroprusside (0.01 - 30 μM). 3-MQ or IBMX at various concentrations (10 - 300 μM) concentration-dependently and significantly inhibited cAMP- and cGMP-PDE activities of the trachealis. The IC50 values of 3-MQ were estimated to be 13.8 and 14.3 μM, respectively. The inhibitory effects of 3-MQ on both enzyme activities were not significantly different from those of IBMX, a non-selective PDE inhibitor. The above results reveal that the mechanisms of relaxant action of 3-MQ may be due to its inhibitory effects on both PDE activities and its subsequent reducing effect on [Ca2+]i of the trachealis.
Abbreviations
3-MQ:3-O-methylquercetin
IBMX:3-isobutyl-1-methylxanthine
VDCCs:voltage dependent calcium channels
cAMP:adenosine 3′,5′-cyclic monophosphate
cGMP:guanosine 3′,5′-cyclic monophosphate
PDE:phosphodiesterase
Key words
3-O-Methylquercetin - Rhamnus nakaharai - Rhamnaceae - guinea-pig trachea - intracellular calcium - phosphodiesterase
Key words
3-O-Methylquercetin - Rhamnus nakaharai - Rhamnaceae - guinea-pig trachea - intracellular calcium - phosphodiesterase
References
- 1 van Hoof L, Vanden Berghe D A, Hatfield G M, Vlietinck A J. Plant antiviral agent; V. 3-Methoxyflavones as potent inhibitors of viral-induced block of cell synthesis. Planta Medica. 1984; 50 513-7
- 2 Castrillo J L, Vanden Berghe D, Carrasco L. 3-Methylquercetin is a potent and selective inhibitor of poliovirus RNA synthesis. Virology. 1986; 152 219-27
- 3 Vrijsen R, Everaert L, Van Hoof L M, Vlietinck A J, Vanden Berghe D A, Boeye A. The poliovirus-induced shut-off of cellular protein synthesis persists in the presence of 3-methylquercetin, a flavonoid which blocks viral protein and RNA synthesis. Antiviral Research. 1987; 7 35-42
- 4 Laekeman G M, Claeys M, Rwangabo P C, Herman A G, Vlietinck A J. Cardiovascular effects of 3-methylqueercetin. Planta Medica. 1986; 6 433-7
- 5 Chiu N Y, Chang K H. The illustrated medicinal plants of Taiwan. 5 Taipei: SMC 1998: 135-6
- 6 Lin C N, Lu C M, Lin H C, Ko F N, Teng C M. Novel antiplatelet naphthalene from Rhamnus nakaharai . Journal of Natural Products. 1995; 58 934-40
- 7 Holroyde M C. The influence of epithelium on the responsiveness of guinea pig isolated teachea. British Journal of Pharmacology. 1986; 87 501-7
- 8 Cook S J, Archer K, Martin A, Buchheit K H, Fozard J R, Müller T, Miller A J, Elliott K RF, Foster R W, Small R C. Further analysis of the mechanisms underlying the tracheal relaxant action of SCA40. British Journal of Pharmacology. 1995; 114 143-51
- 9 Ariëns E J, van Rossum J M. pDx, pAx and pD′x values in the analysis of pharmacodynamics. Archives Internationales de Pharmacodynamie et de Therapie. 1957; 110 275-97
- 10 Ko W C, Kuo S W, Sheu J R, Lin C H, Tzeng S H, Chen C M. Relaxant action mechanisms of quercetin 3,3’,4’,5,7-pentamethyl ether in isolated guinea-pig trachea. New Taipei Journal of Medicine. 1999; 1 98-106
- 11 Sabouni M H, Cushing D J, Makujina S R, Mustafa S J. Inhibition of adenylate cyclase attenuates adenosine receptor-mediated relaxation in coronary artery. Journal of Pharmacology and Experimental Therapeutics. 1991; 254 508-12
- 12 Gruetter C A, Kodowitz P J, Ignarro L. Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerine, sodium nitrate and amyl nitrite. Canadian Journal of Physiology and Pharmacology. 1981; 59 150-6
- 13 Murray M A, Boyle J P, Small R C. Cromakalim-induced relaxation of guinea-pig isolated trachealis: Antagonism by glibenclamide and by phentolamine. British Journal of Pharmacology. 1989; 98 856-74
- 14 Ishii K, Chang B, Kerwin J F, Huang Z J, Murad F. N ω-Nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. European Journal of Pharmacology. 1990; 176 219-23
- 15 Tsien R W. Calcium channels in excitable cell membranes. Annual Review of Physiology. 1983; 45 341-58
- 16 Eglen R M, Reddy H, Watson N, Challiss R AJ. Muscarinic acetylcholine receptor subtypes in smooth muscle. Trends in Pharmacological Sciences. 1994; 15 114-9
- 17 Seamon K B, Daly J W, Metzger H, DeSouza N J, Reden J. Structure-activity relationships for activation of adenylate cyclase by the diterpene forskolin and its derivatives. Journal of Medicinal Chemistry. 1983; 26 436-9
- 18 Schultz K, Schultz K, Schultz G. Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens. Nature. 1977; 265 750-1
- 19 Westfall D P, Gerthoffer W T, Webb R C. Vasodilators and nitric oxide synthase. In: Brody TM, Larner J, Minneman KP, editors Mosby St. Louis; 1998: 239-47
- 20 Ogawa K, Takagi K, Satake T. Mechanism of xanthine-induced relaxation of guinea-pig isolated trachealis muscle. British Journal of Pharmacology. 1989; 97 542-6
- 21 Tanaka H, Ogawa K, Takagi K, Satake T, Hidaka H. Inhibition of cyclic GMP phosphodiesterase by xanthine derivatives relaxes guinea-pig trachealis smooth muscle. Clinical and Experimental Pharmacology and Physiology. 1991; 18 163-8
Prof. Wun-Chang Ko
Graduate Institute of Medical Sciences
Taipei Medical University
250 Wu-Hsing St.
Taipei 110
Taiwan
R.O.C.
Email: wc_ko@tmu.edu.tw
Fax: +886-2-2377-7639